These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 17344876

  • 1. Overhauling clinical trials.
    Scott CT, Baker M.
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract] [Full Text] [Related]

  • 2. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E, Sapirstein W, Ahn C, Swain J, Zuckerman B.
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trial design issues in schizophrenic research.
    Casey DE.
    J Clin Psychiatry; 2001 Sep; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. External influences on protocol design.
    Spilker B.
    Epilepsy Res Suppl; 1993 Sep; 10():115-24. PubMed ID: 8251087
    [No Abstract] [Full Text] [Related]

  • 9. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW.
    Wall St J (East Ed); 2006 Jul 10; ():B1, B8. PubMed ID: 16858817
    [No Abstract] [Full Text] [Related]

  • 10. Patients, physicians, and clinical trials: the other side of the coins.
    Abramson SB, Flexner C, Snyderman R, Dieterich DT, Korn D, Temple R, Sherwood L, Goldblatt D.
    J Investig Med; 1999 Sep 10; 47(8):343-57. PubMed ID: 10510587
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA.
    Food Drug Law J; 2003 Sep 10; 58(1):103-27. PubMed ID: 12739592
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A, United States Food And Drug Administration.
    Nat Biotechnol; 2005 May 10; 23(5):510. PubMed ID: 15877053
    [No Abstract] [Full Text] [Related]

  • 16. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC, Cross JT.
    Clin Pharmacol Ther; 2007 Jul 10; 82(1):12-4. PubMed ID: 17571068
    [No Abstract] [Full Text] [Related]

  • 17. Drive for drugs leads to baby clinical trials.
    Nature; 2006 Mar 23; 440(7083):406-7. PubMed ID: 16554774
    [No Abstract] [Full Text] [Related]

  • 18. Hypothesis: a single clinical trial plus causal evidence of effectiveness is sufficient for drug approval.
    Peck CC, Rubin DB, Sheiner LB.
    Clin Pharmacol Ther; 2003 Jun 23; 73(6):481-90. PubMed ID: 12811358
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The special treatment.
    Osborne R.
    Nat Biotechnol; 2008 May 23; 26(5):487-9. PubMed ID: 18464770
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.